FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of formula (VA-1), wherein WRW2 and WRW4 are independently specified in a hydrogen atom, -CN, -CF3, halogen, linear or branched (C1-C6)alkyl, a 3-12-merous cycloaliphatic group or phenyl, wherein WRW2 and WRW4 are independently and optionally substituted by up to three substitutes specified in -OR′, -CF3, -OCF3, -SR′, -S(O)R′, -SO2R′, halogen, -CN, -COOR′, -(CH2)OR′, -CH2CN, phenyl, phenoxy group, -N(R′)(R′), -NR′C(O)OR′, -NR′C(O)R′, -(CH2)N(R′)(R′); WRW5 is specified in a group consisting of a hydrogen atom, -CN, -CHF2, -N(R′)2, -NHC(O)R′, -NHC(O)OR′, -NHSO2R′, -OR′, -CH2OH, -CH2N(R′)2, -C(O)OR′, -SO2NHR′, -SO2N(R′)2 or -CH2NHC(O)OR′; X means a bond; Rx means the hydrogen atom; R′ is independently specified in the hydrogen atom, (C1-C8)aliphatic group, (C3-C8)cycloalkyl or phenyl. Also, the invention refers to a pharmaceutical composition possessing the properties of modulators of ATP-binding cartridge (ABC) transporters and containing the compound of formula , and to a method of treating or relieving a severity in a patient, wherein the above disease is specified in mucoviscidosis, hereditary emphysema, chronic obstructive pulmonary disease (COPD) or dry eye disease.
EFFECT: compound of formula (VA-1) as the modulators of the ATP-binding cartridge (ABC) transporters.
24 cl, 14 tbl, 83 ex
Title | Year | Author | Number |
---|---|---|---|
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2005 |
|
RU2556984C2 |
METHOD OF MODULATING TRANSPORTERS OF ATP-BINDING CASSETTE | 2005 |
|
RU2525115C2 |
ATP-BINDING CASETTE TRANSPORTER MODULATORS | 2005 |
|
RU2382779C2 |
MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
TREATMENT METHOD | 2012 |
|
RU2621148C2 |
INDANONE DERIVATIVE, ITS PHARMACEUTICALLY ACCEPTABLE SALT OR ENANTIOMER, METHOD FOR PRODUCING IT AND PHARMACEUTICAL COMPOSITION CONTAINING IT AND APPLICABLE FOR PREVENTING OR TREATING VIRAL DISEASE | 2012 |
|
RU2574591C2 |
ARYL-SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | 2010 |
|
RU2575168C2 |
PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
NEW ALKYLATING AGENTS | 2013 |
|
RU2632206C2 |
QUINOLINIL-CONTAINING COMPOUND, ITS PHARMACEUTICAL COMPOSITION AND USE | 2020 |
|
RU2803116C2 |
Authors
Dates
2014-09-10—Published
2005-06-24—Filed